Related Experiment Video
Updated: Aug 15, 2025
06:02
Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model
Published on: July 26, 2011
36.8K
Pathogenesis of Alzheimer's Disease
1Department of Pathology, Grossman School of Medicine, New York University, New York, NY 10016, USA.
International Journal of Molecular Sciences
|January 8, 2023
Summary
Alzheimer's disease (AD) is a common dementia. Research explores its underlying mechanisms and potential treatments.
Area of Science:
- Neuroscience
- Gerontology
- Pathology
Background:
- Alzheimer's disease (AD) is the predominant cause of dementia, affecting millions globally.
- Understanding the complex pathophysiology of AD is crucial for developing effective interventions.
- Current research focuses on early detection and therapeutic strategies to slow disease progression.
Discussion:
- Investigating the molecular and cellular changes in the brain associated with Alzheimer's disease.
- Exploring the role of genetic and environmental factors in AD pathogenesis.
- Analyzing the impact of AD on cognitive function and daily living.
Key Insights:
- Early diagnosis of Alzheimer's disease can significantly improve patient outcomes.
- Identifying novel biomarkers for Alzheimer's disease is essential for timely intervention.
- Therapeutic approaches targeting amyloid plaques and tau tangles show promise in preclinical studies.
Outlook:
- Future research directions include personalized medicine approaches for AD treatment.
- Developing effective preventative strategies for Alzheimer's disease is a major goal.
- Continued investigation into the neurobiological underpinnings of AD will drive therapeutic innovation.
More Related Videos
Related Concept Videos
01:26Alzheimer's Disease: Overview
600
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
600
01:22Alzheimer's Disease: Treatment
238
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
238
03:03Amyloid Fibrils
9.7K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.7K
01:15Parkinson's Disease: Overview
645
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
645
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
831
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
831
01:23Role of Neurotransmitters in Memory
714
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
714